PIMREGP4

Across TCGA pan-cancer cohorts, PIMREGP4 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of PIMREGP4’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where PIMREGP4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PIMREGP4 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

STAD, PAAD, and BRCA are the cancer types where PIMREGP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PIMREGP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.181	.003	4	view →
PAAD	Male	All	−0.130	.005	2	view →
BRCA	Female	All	+0.079	.043	2	view →
LIHC	All	II,III,IV	+0.017	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

PIMREGP4–STAD

Open the STAD breakdown →